Lupin launches generic joint pain drug in US market

Lupin launches generic joint pain drug in US market

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid

PTIUpdated: Friday, December 09, 2022, 03:17 PM IST
article-image
Image credit: Wikipedia (Representative)

Lupin announced on Friday that it has launched a generic version of Pennsaid, which is used to treat knee pain caused by osteoarthritis, in the American market.

The company's product- Diclofenac Sodium Topical Solution 2 per cent- is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.

As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of USD 509 million in the US.

RECENT STORIES

Mumbai Real Estate News: Reliance Industries Buys 3 Luxury Homes At One Altamount Road For ₹85...
Mumbai Real Estate News: Reliance Industries Buys 3 Luxury Homes At One Altamount Road For ₹85...
Government Approves Startup India 2.0 With ₹10,000 Crore Corpus To Boost Deep Tech & Regional...
Government Approves Startup India 2.0 With ₹10,000 Crore Corpus To Boost Deep Tech & Regional...
Signature Global Forms 50:50 JV With RMZ Group For ₹1,283 Crore Gurugram Mixed-Use Project
Signature Global Forms 50:50 JV With RMZ Group For ₹1,283 Crore Gurugram Mixed-Use Project
Ixigo Acquires 60% Stake In Spain's Trenes For €11.7 Million, Marks First Major International...
Ixigo Acquires 60% Stake In Spain's Trenes For €11.7 Million, Marks First Major International...
DP World Appoints New Leadership Following Reports Of Former CEO’s Ties To Jeffrey Epstein
DP World Appoints New Leadership Following Reports Of Former CEO’s Ties To Jeffrey Epstein